Renaissance Technologies - CATALYST BIOSCIENCES INC ownership

CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 74 filers reported holding CATALYST BIOSCIENCES INC in Q2 2018. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of CATALYST BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$285
+4.8%
590,687
-23.7%
0.00%
Q2 2023$272
+50.3%
774,386
-11.6%
0.00%
Q1 2023$181
-71.1%
875,886
-26.2%
0.00%
-100.0%
Q4 2022$626
-99.9%
1,186,986
+7.8%
0.00%0.0%
Q3 2022$555,000
-60.9%
1,101,270
+38.2%
0.00%
-50.0%
Q2 2022$1,419,000
+83.8%
796,986
-31.9%
0.00%
+100.0%
Q1 2022$772,000
-52.3%
1,169,862
-34.0%
0.00%
-50.0%
Q4 2021$1,620,000
+887.8%
1,771,908
+4353.7%
0.00%
Q3 2021$164,000
-91.6%
39,785
-91.1%
0.00%
-100.0%
Q2 2021$1,941,000
+111.4%
448,197
+208.0%
0.00%
+100.0%
Q4 2020$918,000
-14.9%
145,508
-42.0%
0.00%0.0%
Q3 2020$1,079,000
+122.0%
251,001
+203.1%
0.00%
Q2 2020$486,000
+157.1%
82,808
+91.2%
0.00%
Q1 2020$189,000
-43.4%
43,308
-11.8%
0.00%
Q4 2019$334,000
+183.1%
49,108
+206.8%
0.00%
Q2 2019$118,000
-91.8%
16,008
-90.9%
0.00%
-100.0%
Q1 2019$1,433,000
-8.7%
176,690
-11.2%
0.00%
-50.0%
Q4 2018$1,570,000
-67.0%
198,998
-54.9%
0.00%
-60.0%
Q3 2018$4,754,000
-77.6%
440,973
-61.4%
0.01%
-58.3%
Q2 2018$21,199,000
+47.7%
1,142,946
+105.4%
0.01%
-25.0%
Q1 2018$14,354,000
+196.1%
556,373
+56.6%
0.02%
+220.0%
Q4 2017$4,847,000
+187.0%
355,373
+6.5%
0.01%
+150.0%
Q3 2017$1,689,000
+7.0%
333,773
-1.7%
0.00%0.0%
Q2 2017$1,579,000
+154.7%
339,673
+416.4%
0.00%
+100.0%
Q1 2017$620,00065,7730.00%
Other shareholders
CATALYST BIOSCIENCES INC shareholders Q2 2018
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 2,635,014$10,830,0004.93%
22NW, LP 1,429,242$5,874,0001.75%
Ghost Tree Capital, LLC 1,000,000$4,110,0001.20%
Sio Capital Management, LLC 623,892$2,564,0000.82%
ACUTA CAPITAL PARTNERS, LLC 365,000$1,500,0000.53%
Nantahala Capital Management 2,432,212$9,996,0000.32%
Parkman Healthcare Partners LLC 133,449$548,0000.14%
Ikarian Capital, LLC 454,346$1,867,0000.13%
Orbimed Advisors 2,711,600$11,145,0000.12%
AlphaCentric Advisors LLC 114,000$469,0000.12%
View complete list of CATALYST BIOSCIENCES INC shareholders